Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.

By Michael Miller, N. Stone, Christie M. Ballantyne, V. Bittner, M. Criqui, H. Ginsberg, A. Goldberg, W. Howard, M. Jacobson, P. Kris-Etherton and 4 more. Circulation, 2011

1,805 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/dbffa13ce32c98e359a95d28a09865795c3bb331

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

In Nutrition and Dietetics

N. Rifai

Citations in the corpus

Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome (2019, background): “Typically, weight loss is expected to promote lower TGs. Loss of 5-10% of body weight should lead to a 20% reduction in TGs (Miller et al., 2011).”
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, background): “Management of individuals with fasting triglycerides >500 mg/dL has been addressed in an AHA statement (45).”
Loss-of-Function Mutations in APOC 3 , Triglycerides , and Coronary Disease (2014, neutral): “New England Journal of Medicine, 371(1), 22-31.”
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Med (2016, background): “Curiosamente, este valor de corte es idéntico al propuesto anteriormente para triglicéridos en ayunas por la American Heart Association (14) y la EAS (12).”
Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (2014, background): “Management of individuals with fasting triglycerides >500 mg/dL has been addressed in an AHA statement (45).”